呼吸困难作为急性失代偿性心力衰竭治疗临床试验的终点指标。 - Suppr

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.

作者信息

Teerlink John R

机构信息

Heart Failure Clinic, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, School of Medicine, San Francisco, Calif 94121-1545, USA.

出版信息

Am Heart J. 2003 Feb;145(2 Suppl):S26-33. doi: 10.1067/mhj.2003.151.

DOI:10.1067/mhj.2003.151

PMID:12594449

Abstract

摘要

相似文献

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.

Am Heart J. 2003 Feb;145(2 Suppl):S26-33. doi: 10.1067/mhj.2003.151.

The development of new medical treatments for acute decompensated heart failure.

Heart Fail Monit. 2002;2(4):129-37.

Pharmacologic therapy for acute heart failure.

Cardiol Clin. 2007 Nov;25(4):539-51; vi. doi: 10.1016/j.ccl.2007.08.007.

New therapeutic choices in the management of acute congestive heart failure.

Rev Cardiovasc Med. 2001;2 Suppl 2:S19-24.

New and emerging drug therapies for the management of acute heart failure.

Intern Med J. 2003 Nov;33(11):515-20. doi: 10.1046/j.1445-5994.2003.00483.x.

Optimizing outcomes in the patient with acute decompensated heart failure.

Am Heart J. 2006 Mar;151(3):571-9. doi: 10.1016/j.ahj.2005.04.034.

Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.

Am Heart J. 2003 Feb;145(2 Suppl):S3-17. doi: 10.1067/mhj.2003.149.

Overview of emerging pharmacologic agents for acute heart failure syndromes.

Eur J Heart Fail. 2008 Feb;10(2):201-13. doi: 10.1016/j.ejheart.2008.01.002.

The lost decade of nesiritide.

N Engl J Med. 2011 Jul 7;365(1):81-2. doi: 10.1056/NEJMe1103116.

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

Am Heart J. 2009 Feb;157(2):271-7. doi: 10.1016/j.ahj.2008.07.031. Epub 2008 Dec 19.

引用本文的文献

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction.

Front Cardiovasc Med. 2020 Dec 7;7:602251. doi: 10.3389/fcvm.2020.602251. eCollection 2020.

Clinical profiles in acute heart failure: an urgent need for a new approach.

ESC Heart Fail. 2019 Jun;6(3):464-474. doi: 10.1002/ehf2.12439. Epub 2019 Apr 25.

Evaluation of a provocative dyspnea severity score in acute heart failure.

Am Heart J. 2016 Feb;172:34-41. doi: 10.1016/j.ahj.2015.10.009. Epub 2015 Oct 20.

Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score.

J Card Fail. 2016 Nov;22(11):853-858. doi: 10.1016/j.cardfail.2015.12.015. Epub 2015 Dec 21.

Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review.

Am J Emerg Med. 2015 Feb;33(2):133-41. doi: 10.1016/j.ajem.2014.09.009. Epub 2014 Sep 18.

Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.

Am J Cardiol. 2015 Jan 1;115(1):75-81. doi: 10.1016/j.amjcard.2014.09.048. Epub 2014 Oct 15.

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.

Am Heart J. 2014 Aug;168(2):142-9. doi: 10.1016/j.ahj.2014.05.009. Epub 2014 May 24.

The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients.

Clinics (Sao Paulo). 2014;69(5):341-6. doi: 10.6061/clinics/2014(05)08.

Learning from recent trials and shaping the future of acute heart failure trials.

Am Heart J. 2013 Oct;166(4):629-35. doi: 10.1016/j.ahj.2013.08.001. Epub 2013 Sep 13.

Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure.

Am J Emerg Med. 2012 Jul;30(6):872-80. doi: 10.1016/j.ajem.2011.06.005. Epub 2011 Aug 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.

作者信息

Teerlink John R

机构信息

Heart Failure Clinic, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, School of Medicine, San Francisco, Calif 94121-1545, USA.

出版信息

Am Heart J. 2003 Feb;145(2 Suppl):S26-33. doi: 10.1067/mhj.2003.151.

DOI:10.1067/mhj.2003.151

PMID:12594449

Abstract

摘要

相似文献

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.

Am Heart J. 2003 Feb;145(2 Suppl):S26-33. doi: 10.1067/mhj.2003.151.

The development of new medical treatments for acute decompensated heart failure.

Heart Fail Monit. 2002;2(4):129-37.

Pharmacologic therapy for acute heart failure.

Cardiol Clin. 2007 Nov;25(4):539-51; vi. doi: 10.1016/j.ccl.2007.08.007.

New therapeutic choices in the management of acute congestive heart failure.

Rev Cardiovasc Med. 2001;2 Suppl 2:S19-24.

New and emerging drug therapies for the management of acute heart failure.

Intern Med J. 2003 Nov;33(11):515-20. doi: 10.1046/j.1445-5994.2003.00483.x.

Optimizing outcomes in the patient with acute decompensated heart failure.

Am Heart J. 2006 Mar;151(3):571-9. doi: 10.1016/j.ahj.2005.04.034.

Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.

Am Heart J. 2003 Feb;145(2 Suppl):S3-17. doi: 10.1067/mhj.2003.149.

Overview of emerging pharmacologic agents for acute heart failure syndromes.

Eur J Heart Fail. 2008 Feb;10(2):201-13. doi: 10.1016/j.ejheart.2008.01.002.

The lost decade of nesiritide.

N Engl J Med. 2011 Jul 7;365(1):81-2. doi: 10.1056/NEJMe1103116.

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

Am Heart J. 2009 Feb;157(2):271-7. doi: 10.1016/j.ahj.2008.07.031. Epub 2008 Dec 19.

引用本文的文献

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction.

Front Cardiovasc Med. 2020 Dec 7;7:602251. doi: 10.3389/fcvm.2020.602251. eCollection 2020.

Clinical profiles in acute heart failure: an urgent need for a new approach.

ESC Heart Fail. 2019 Jun;6(3):464-474. doi: 10.1002/ehf2.12439. Epub 2019 Apr 25.

Evaluation of a provocative dyspnea severity score in acute heart failure.

Am Heart J. 2016 Feb;172:34-41. doi: 10.1016/j.ahj.2015.10.009. Epub 2015 Oct 20.

Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score.

J Card Fail. 2016 Nov;22(11):853-858. doi: 10.1016/j.cardfail.2015.12.015. Epub 2015 Dec 21.

Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review.

Am J Emerg Med. 2015 Feb;33(2):133-41. doi: 10.1016/j.ajem.2014.09.009. Epub 2014 Sep 18.

Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.

Am J Cardiol. 2015 Jan 1;115(1):75-81. doi: 10.1016/j.amjcard.2014.09.048. Epub 2014 Oct 15.

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.

Am Heart J. 2014 Aug;168(2):142-9. doi: 10.1016/j.ahj.2014.05.009. Epub 2014 May 24.

The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients.

Clinics (Sao Paulo). 2014;69(5):341-6. doi: 10.6061/clinics/2014(05)08.

Learning from recent trials and shaping the future of acute heart failure trials.

Am Heart J. 2013 Oct;166(4):629-35. doi: 10.1016/j.ahj.2013.08.001. Epub 2013 Sep 13.

Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure.

Am J Emerg Med. 2012 Jul;30(6):872-80. doi: 10.1016/j.ajem.2011.06.005. Epub 2011 Aug 25.

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.

作者信息

机构信息

出版信息

相似文献

引用本文的文献